Clinical Trials in Los Angeles

Showing 181-200 of 8,055 trials

Early Feeds in Gastroschisis

NCT06878950

This study aims to evaluate the feasibility of initiating early feeds in neonates with gastroschisis, a condition where infants are born with their intestines outside the body.

Gastroschisis

University of California, Davis20 participantsStarted Feb 2025

Los Angeles, California, United States • Sacramento, California, United States

RECRUITINGPHASE2< 1 mile

A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

NCT07015983

The purpose of this study is to evaluate the efficacy, safety and drug levels of CC-97540 in participants with active systemic lupus erythematosus (SLE) including lupus nephritis with inadequate response to glucocorticoids and at least 2 immunosuppressants.

Lupus Erythematosus, SystemicLupus Nephritis

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company89 participantsStarted Jul 2025

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Scottsdale, Arizona, United States +99 more locations

Early Feeds in Gastroschisis

A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

Find Trials by Condition in Los Angeles

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Actinium Therapy for Late-stage Aggressive Sarcomas

PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease

Virtual Reality for ICU Delirium Prevention

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

Donidalorsen Treatment in Children With Hereditary Angioedema

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease

A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes

Empathic Communication Skills (ECS) Training

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma

ELEVATE High-Risk PCI Pivotal Study

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE